Cystagon is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Cysteamine Bitartrate.
Product ID | 0378-9045_263f8238-b6bd-42fa-b339-f27ede4026e2 |
NDC | 0378-9045 |
Product Type | Human Prescription Drug |
Proprietary Name | Cystagon |
Generic Name | Cysteamine Bitartrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2005-04-11 |
Marketing End Date | 2030-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020392 |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | CYSTEAMINE BITARTRATE |
Active Ingredient Strength | 150 mg/1 |
Pharm Classes | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2005-04-11 |
Marketing End Date | 2030-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020392 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-04-11 |
Marketing Category | NDA |
Application Number | NDA020392 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1994-08-15 |
Marketing End Date | 2018-09-04 |
Ingredient | Strength |
---|---|
CYSTEAMINE BITARTRATE | 150 mg/1 |
SPL SET ID: | f495b76d-96c6-48e5-8fa3-30a4336628eb |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-9040 | Cystagon | cysteamine bitartrate |
0378-9045 | Cystagon | cysteamine bitartrate |
75987-100 | PROCYSBI | Cysteamine bitartrate |
75987-101 | PROCYSBI | Cysteamine bitartrate |
75987-140 | PROCYSBI | Cysteamine bitartrate |
75987-145 | PROCYSBI | Cysteamine bitartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CYSTAGON 74414870 1907806 Live/Registered |
Mylan Pharmaceuticals Inc. 1993-07-21 |